BridgeBio has demonstrably boosted this development of an novel solution for amyloid heart disease, leveraging the investigational drug. Early patient data indicates significant improvements for those suffering by the https://bridgebio628289.wssblogs.com/42010877/bridgebio-progresses-cardiac-amyloidosis-therapy-using-the-drug